The DOI matches its Crossref record; 300 of the 302 references it cites were found in a registry or an index.
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
The PHQ-9: A New Depression Diagnostic and Severity Measure
Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898
(1962) · Medical Entomology and Zoology · Cited by 4,856
The Obsessive-Compulsive Inventory: Development and validation of a short version.
Foa, E. B., Huppert, J. D., Leiberg, S., Langner, R., Kichic, R., Hajcak, G., & Salkovskis, P. M. (2002) · Psychological Assessment · doi:10.1037/1040-3590.14.4.485 · Cited by 2,959
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799
The yale global tic severity scale: initial testing of a clinician-rated scale of tic severity
LECKMAN, J. F., RIDDLE, M. A., HARDIN, M. T., ORT, S. I., SWARTZ, K. L., STEVENSON, J., & COHEN, D. J. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198907000-00015 · Cited by 2,146
(1993) · PubMed · Cited by 1,900
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.885 · Cited by 1,421
Cited by
Sorted by citations
Items 501–600 of 1,002
Zheng, H., Yang, W., Zhang, B., Hua, G., Wang, S., Jia, F., Guo, G., Wang, W., & Quan, D. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.059 · Cited by 17
Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease
Court, T., Lavikainen, P., Taipale, H. T., Tiihonen, J., Tanskanen, A. J., Hartikainen, S. A., & Tolppanen, A. (2020) · Neurology · doi:10.1212/wnl.0000000000009435 · Cited by 17
McLaughlin, N. C. R., Dougherty, D. D., Eskandar, E. N., Ward, H. E., Foote, K. D., Malone, D. A., Machado, A. G., Wong, W., Sedrak, M. F., Goodman, W. K., et al. (2021) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2021.100785 · Cited by 17
Zheng, H., Luo, G., Yao, S., Wang, S., Guo, G., Quan, D., & Gao, J. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.10.019 · Cited by 17
Cognitive Fluctuations and the Lucid Interval in Dementia: Implications for Testamentary Capacity.
Shulman, K. I., Hull, I. M., DeKoven, S., Amodeo, S., Mainland, B. J., & Herrmann, N. (2015) · PubMed · Cited by 17
Poppe, C., Müller, S. T., Greil, W., Walder, A., Grohmann, R., & Stübner, S. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.035 · Cited by 17
Cervin, M., Perrin, S. G., Olsson, E., Claesdotter‐Knutsson, E., & Lindvall, M. L. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.11.048 · Cited by 17
Moreira, L. V., Bins, H. D. D. C., Torresan, R. C., Ferro, C., Harttmann, T., Petribú, K., Juruena, M. F., do Rosário, M. C., & Ferrão, Y. A. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.12.004 · Cited by 17
Zaboski, B. A., & Bednarek, L. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072442 · Cited by 16
Risk factors of pneumonia in persons with and without Alzheimer’s disease: a matched cohort study
Järvinen, H., Tolppanen, A., & Hartikainen, S. A. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-03940-z · Cited by 16
Kamble, S. R., & Dandekar, M. P. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176014 · Cited by 16
Tjelle, K., Opstad, H. B., Solem, S., Kvale, G., Wheaton, M. G., Björgvinsson, Þ., Hansen, B. K. A., & Hagen, K. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05780-6 · Cited by 17
Clinical Outcomes and Cost-Effectiveness of Collaborative Dementia Care
Michalowsky, B., Blotenberg, I., Platen, M., Teipel, S. J., Kilimann, I., Portacolone, E., Bohlken, J., Rädke, A., Buchholz, M., Scharf, A., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.19282 · Cited by 16
Psilocybin reduces grooming in the SAPAP3 knockout mouse model of compulsive behaviour
Gattuso, J. J., Wilson, C., Hannan, A. J., & Renoir, T. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110202 · Cited by 16
Cognitive behavioural therapy for obsessive-compulsive symptoms in schizophrenia
Schirmbeck, F. N., & Zink, M. (2013) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x13000123 · Cited by 16
Albert, U., Barbaro, F., Aguglia, A., Maina, G., & Bogetto, F. (2012) · Rivista di psichiatria · doi:10.1708/1139.12553 · Cited by 16
Langford, A. V., Chen, T. F., Roberts, C., & Schneider, C. R. (2019) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2019.08.035 · Cited by 16
Elbejjani, M., Wahab, K., Hachem, R. E., Tanielian, M., Feghali, L., & Assaf, G. (2021) · Psychogeriatrics · doi:10.1111/psyg.12722 · Cited by 17
Patel, S. R., Galfalvy, H., Kimeldorf, M. B., Dixon, L. B., & Simpson, H. B. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201600092 · Cited by 18
Self-citationPagliaccio, D., Cha, J., He, X., Cyr, M., Yanes-Lukin, P. K., Goldberg, P. H., Fontaine, M., Rynn, M. A., & Marsh, R. (2019) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13191 · Cited by 16
Coles, M. E., & Stewart, E. (2019) · Chronobiology International · doi:10.1080/07420528.2019.1624563 · Cited by 15
Advances in the management of treatment-resistant anxiety disorders
Lanouette, N. M., & Stein, M. B. (2010) · Focus · doi:10.1176/foc.8.4.foc501 · Cited by 15
Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD)
DiBello, J. R., Lü, Y., Swartz, J., Bortnichak, E. A., Liaw, K., Zhong, W., & Liu, X. (2023) · BMC Neurology · doi:10.1186/s12883-023-03447-5 · Cited by 15
Psychedelics, OCD and related disorders: A systematic review
Graziosi, M., Rohde, J. S., Tiwari, P., Siev, J., & Yaden, D. B. (2024) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2024.100873 · Cited by 20
Schepisi, C., Carolis, L. D., & Nencini, P. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2938-z · Cited by 15
Diuretics: A possible keystone in upholding cognitive health
DeLoach, T., & Beall, J. (2018) · Mental Health Clinician · doi:10.9740/mhc.2018.01.033 · Cited by 15
Lu, Z. A., Mu, W., Osborne, L. M., & Cordner, Z. A. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225119 · Cited by 15
Dell’Osso, B. M., Vismara, M. E. M., Benatti, B., Cirnigliaro, G., Grancini, B. M., Fineberg, N. A., Ameringen, M. V., Hollander, E., Stein, D. J., Menchón, J. M., et al. (2019) · CNS Spectrums · doi:10.1017/s1092852919001068 · Cited by 15
Self-citationAn Evaluation of Family-Based Treatment for OCD in Japan: A Pilot Randomized Controlled Trial
Kobayashi, Y., Kanie, A., Nakagawa, A., Takebayashi, Y., Shinmei, I., Nakayama, N., Yamaguchi, K., Nakayama, C., Hirabayashi, N., Mimura, M., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00932 · Cited by 15
Shaw, A. M., Halliday, E. R., & Ehrenreich, J. T. (2020) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2020.100552 · Cited by 16
Zaboski, B. A., Stern, E. F., Skosnik, P. D., & Pittenger, C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.703398 · Cited by 17
Zhang, T., Lu, L., Didonna, F., Wang, Z., Zhang, H., & Fan, Q. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.661807 · Cited by 15
The prefrontal cortex and neurosurgical treatment for intractable OCD
Rasmussen, S. A., & Goodman, W. K. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01149-5 · Cited by 16
Sakai, Y., Sakai, Y., Abe, Y., Narumoto, J., & Tanaka, S. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111275 · Cited by 16
Castle, D. J., Feusner, J. D., Laposa, J. M., Richter, P. M. A., Hossain, R., Lusicic, A., & Drummond, L. M. (2022) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2022.152357 · Cited by 20
Kwan, R. Y. C., Leung, M. C. P., & Lai, C. K. Y. (2014) · Trials · doi:10.1186/1745-6215-15-410 · Cited by 15
Miranda‐Castillo, C., Mascayano, F., Herrera, A. R., Ghigliotto, F. M., & Guerra, L. S. (2013) · Universitas Psychologica · doi:10.11144/javeriana.upsy12-2.ipec · Cited by 15
Obsessive-Compulsive Behavior as Presenting Symptom of Primary Antiphospholipid Syndrome
Roie, E. V., Labarque, V., Renard, M., Geet, C. V., & Gabriëls, L. A. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31828acfbc · Cited by 15
Specialized cognitive behavior therapy for treatment resistant obsessive compulsive disorder.
Sookman, D., & Steketee, G. S. (2009) · Cited by 15
Ten‐year follow‐up study of Japanese patients with obsessive–compulsive disorder
Nakajima, A., Matsuura, N., Mukai, K., Yamanishi, K., Yamada, H., Maebayashi, K., Hayashida, K., & Matsunaga, H. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12661 · Cited by 15
Gadallah, A.-H., Ebada, M. A., Gadallah, A., Ahmed, H., Rashad, W., Eid, K. A., Bahbah, E. I., & Alkanj, S. (2020) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2020.100529 · Cited by 15
Droogsma, E., van Asselt, D., Diekhuis, M., Veeger, N., van der Hooft, C., & De Deyn, P. P. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215000289 · Cited by 15
Clinical practice with antidementia and antipsychotic drugs: Audit from a geriatric clinic in India
Prakash, O., Prasad, K., Gupta, H., Bharath, S., Sivakumar, P. T., Kumar, C., & Varghese, M. (2009) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.58292 · Cited by 15
Treatment adequacy of anxiety disorders among young adults in Finland
Kasteenpohja, T., Marttunen, M., Aalto-Setälä, T., Perälä, J., Saarni, S. I., & Suvisaari, J. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0766-0 · Cited by 14
Cosmetic presentations and challenges of body dysmorphic disorder and its collaborative management
Shivakumar, S., Jafferany, M., Sood, S., & Sushruth, V. (2021) · Journal of Cutaneous and Aesthetic Surgery · doi:10.4103/jcas.jcas_180_20 · Cited by 14
Noda, Y., Fujii, K., Tokura, F., Nakajima, S., & Kitahata, R. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050875 · Cited by 14
Management and Treatment of Obsessive-Compulsive Disorder (OCD): A Literature Review
Elsouri, K. N., Heiser, S., Cabrera, D., Alqurneh, S., Hawat, J., & Demory, M. L. (2024) · Cureus · doi:10.7759/cureus.60496 · Cited by 14
Artificial Intelligence in Obsessive-Compulsive Disorder: A Systematic Review
Kim, J., Pacheco, J. P. G., Golden, A., Aboujaoude, E. N., van Roessel, P., Gandhi, A., Mukunda, P., Avanesyan, T., Xue, H., Adeli, E., et al. (2025) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-025-00359-8 · Cited by 14
Long-Term Efficacy of Galantamine in Alzheimer’s Disease: The Okayama Galantamine Study (OGS)
Nakano, Y., Matsuzono, K., Yamashita, T., Ohta, Y., Hishikawa, N., Sato, K., Deguchi, K., & Abe, K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150308 · Cited by 14
Exploring Retrospective Biases in Obsessive-Compulsive Disorder: an Experience-Sampling Study
Kelly, J. M., Kertz, S. J., Simpson, R., Bloch, M. H., & Pittenger, C. (2018) · Journal of Technology in Behavioral Science · doi:10.1007/s41347-018-0078-y · Cited by 14
Giménez, M., Cano, M., Martínez‐Zalacaín, I., Real, E., Alonso, P., Segalàs, C., Munuera, J., Kegeles, L. S., Weinstein, J. J., Xu, X., et al. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-01056-3 · Cited by 15
Vedel, I., Sheets, D. J., McAiney, C. A., Clare, L., Brodaty, H., Mann, J., Anderson, N. D., Liu-Ambrose, T. Y. L., Rojas‐Rozo, L., Loftus, L., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12086 · Cited by 14
Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder
Harmelech, T., Roth, Y., & Tendler, A. (2022) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2022.10.003 · Cited by 15
Psychotherapy and medication management strategies for obsessive-compulsive disorder
Walsh, K. H., & McDougle (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s13205 · Cited by 15
Dream Recall and Dream Content in Obsessive-Compulsive Patients
Kuelz, A. K., Stotz, U., Riemann, D. W., Schredl, M., & Voderholzer, U. (2010) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3181e9dd65 · Cited by 14
Commonly asked questions in the treatment of obsessive-compulsive disorder
Arumugham, S. S., & Reddy, Y. C. J. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.874287 · Cited by 15
Demographic and Clinical Profile of Patients With Dementia Receiving Electroconvulsive Therapy
Zhang, Q., Sha, S., Ungvari, G. S., Chiu, H. F. K., Ng, C. H., He, H., Forester, B. P., & Xiang, Y. (2016) · Journal of Ect · doi:10.1097/yct.0000000000000314 · Cited by 14
Safer, D. L., Bullock, K. D., & Safer, J. D. (2016) · AACE Clinical Case Reports · doi:10.4158/ep161223.cr · Cited by 14
Yanagisawa, Y., Matsuura, N., Mukai, K., Nakajima, A., Motoyama, M., Yamanishi, K., Yamada, H., Hayashida, K., & Matsunaga, H. (2015) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2015.03.002 · Cited by 14
Vakili, Y., & Gharraee, B. (2014) · Europe PMC (PubMed Central) · Cited by 14
Deep Brain Stimulation for Psychiatric Disorders
Widge, A. S., Arulpragasam, A. R., Deckersbach, T., & Dougherty, D. D. (2015) · Wiley eBooks · doi:10.1002/9781118900772.etrds0103 · Cited by 14
Electroconvulsive therapy for obsessive-compulsive disorder: A retrospective study
Li, K., Long, J., Deng, W., Cheng, B., & Wang, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1040443 · Cited by 14
Bernardi, D., Shannahoff‐Khalsa, D. S., Sale, J., Wright, J. A., Fadiga, L., & Papo, D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1158404 · Cited by 13
The use of antipsychotics in obsessive compulsive disorder
Conti, D., Girone, N., Boscacci, M., Casati, L., Cassina, N., Cerolini, L., Giacovelli, L., Viganò, C. A., Conde, M. M., Cremaschi, L., et al. (2024) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2893 · Cited by 15
Psilocybin in pharmacotherapy of obsessive-compulsive disorder
Owe-Larsson, M., Kamińska, K., Buchalska, B., Mirowska-Guzel, D. M., & Cudnoch‐Jędrzejewska, A. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00633-1 · Cited by 13
A pilot study of magnetic seizure therapy for treatment‐resistant obsessive–compulsive disorder
Tang, V. M., Blumberger, D. M., Weissman, C. R., Dimitrova, J., Throop, A., McClintock, S. M., Voineskos, D., Rajji, T. K., Downar, J. H., Knyahnytska, Y., et al. (2020) · Depression and Anxiety · doi:10.1002/da.23097 · Cited by 13
Sookman, D., Phillips, K. A., Mataix‐Cols, D., & Veale, D. M. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113753 · Cited by 13
Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder: 2021 Update
Noppen, B. L. V., Sassano-Higgins, S. A., Appasani, R. K., & Sapp, F. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20210015 · Cited by 15
Rijksen, D. O. C., Zuidema, S. U., & de Haas, E. C. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210041 · Cited by 13
Evidenzbasierte Pharmakotherapie und andere somatische Therapieverfahren bei Zwangsstörungen
Kordon, A., Zurowski, B., Wahl, K., & Hohagen, F. (2011) · Der Nervenarzt · doi:10.1007/s00115-010-2963-2 · Cited by 15
Evidence-Based Practice Guideline: Wandering
Futrell, M., Melillo, K. D., Remington, R., & Butcher, H. K. (2014) · Journal of Gerontological Nursing · doi:10.3928/00989134-20140911-01 · Cited by 14
Aggression, Agitation, Hyperactivity, and Irritability
Frederiksen, K. S., & Waldemar, G. (2016) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-39138-0_9 · Cited by 13
Dell’Osso, B. M., Cremaschi, L., Oldani, L., & Altamura, A. C. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170505113631 · Cited by 13
Katzman, M. A., Bleau, P., Blier, P., Chokka, P. R., Kjernisted, K. D., & Ameringen, M. V. (2021) · doi:10.32920/14638581 · Cited by 13
Longitudinal course of pharmacotherapy in obsessive–compulsive disorder
Grant, J. E., Mancebo, M. C., Weinhandl, E., Odlaug, B. L., Eisen, J. L., & Rasmussen, S. A. (2013) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283613e4d · Cited by 12
Zhou, S., Wang, Y., Wang, Q., Yang, G., Ren, H., & Bao, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.979158 · Cited by 12
Sookman, D., & Fineberg, N. A. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.12.002 · Cited by 13
Vaccaro, L., Jones, M. K., Menzies, R. G., & Wootton, B. M. (2013) · Clinical Psychologist · doi:10.1111/cp.12019 · Cited by 12
Amitai Abramovitch, A. (2016) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-016-0084-7 · Cited by 12
Harmand, M. G., Meillon, C., Rullier, L., Taddé, B. O., Pimouguet, C., Dartigues, J., Bergua, V., & Amieva, H. (2017) · Aging & Mental Health · doi:10.1080/13607863.2017.1330871 · Cited by 12
Kettunen, R., Taipale, H. T., Tolppanen, A., Tanskanen, A. J., Tiihonen, J., Hartikainen, S. A., & Koponen, M. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2591-5 · Cited by 12
Sijercic, I., Whitfield, K. M., Cassin, S. E., & Antony, M. M. (2020) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2020.100532 · Cited by 12
Mancebo, M. C., Yip, A. G., Boisseau, C. L., Rasmussen, S. A., & Zlotnick, C. (2021) · Behavior Therapy · doi:10.1016/j.beth.2021.02.009 · Cited by 12
Bertolín, S., Alonso, P., Segalàs, C., Real, E., Alemany-Navarro, M., Soria, V., Jiménez‐Múrcia, S., Crespo, J. M., & Menchón, J. M. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.060 · Cited by 12
CO2 reactivity as a biomarker of exposure-based therapy non-response: study protocol
Smits, J. A. J., Monfils, M., Otto, M. W., Telch, M. J., Shumake, J., Feinstein, J. S., Khalsa, S. S., Cobb, A. R., Parsons, E. M., Long, L. J., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04478-x · Cited by 12
Obsessive-Compulsive Syndromes in Schizophrenia: A Case for Polypharmacy?
Schirmbeck, F. N., & Zink, M. (2012) · Springer eBooks · doi:10.1007/978-94-007-5799-8_12 · Cited by 12
The Clinical Problem of Neuropsychiatric Signs and Symptoms in Dementia
Burke, A. D., Hall, G. R., & Tariot, P. N. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000429177.14354.83 · Cited by 12
Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs
Fung, V., Price, M., Busch, A. B., Landrum, M. B., FIREMAN, B. H., Nierenberg, A. A., Dow, W. H., Hui, R. L., Frank, R. G., Newhouse, J. P., et al. (2013) · Medical Care · doi:10.1097/mlr.0b013e31829019c5 · Cited by 13
Hofer, H., Frigerio, S., Frischknecht, E., Gassmann, D., Gutbrod, K., & Müri, R. M. (2012) · Neurocase · doi:10.1080/13554794.2012.690423 · Cited by 12
Richarz, Zhang, Z., Yū, Gaudig, & Schäuble, B. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s38747 · Cited by 12
García‐Alberca, J. M. (2012) · Neurología · doi:10.1016/j.nrl.2012.10.002 · Cited by 21
Grassi, G., Godini, L., Grippo, A., Piccagliani, D., & Pallanti, S. (2014) · Brain stimulation · doi:10.1016/j.brs.2014.10.007 · Cited by 12
Rikala, M., Hartikainen, S. A., Saastamoinen, L., & Korhonen, M. J. (2013) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1384 · Cited by 13
Ito, M., Okumura, Y., Horikoshi, M., Kato, N., Oe, Y., Miyamae, M., Hirabayashi, N., Kanie, A., Nakagawa, A., & Ono, Y. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0779-8 · Cited by 14
Clinicians’ prescription preferences for treating patients with Alzheimer’s disease in Shanghai
Ban, C., Xiao, S., Lin, X., Wang, T., Qiu, Q., Zhu, M., & Li, X. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0055-3 · Cited by 12
Kontis, D., Theochari, E., Nikolakopoulou, M., Andreopoulou, A., Vassos, D., Grigoriou, V., Vassilouli, S., Giannakopoulou, D., Kouloumbi, M., & Tsaltas, E. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.06.009 · Cited by 12
Court, T., Taipale, H. T., Lavikainen, P., Tiihonen, J., Tanskanen, A. J., Hartikainen, S. A., & Tolppanen, A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180594 · Cited by 12
Sekaran, K., & Sudha, M. (2019) · Computer Communications · doi:10.1016/j.comcom.2019.12.049 · Cited by 12
Naaz, S., Balachander, S., Murthy, N. S., Bhagyalakshmi, M. S., Sud, R., Saha, P., Narayanaswamy, J. C., Janardhan Reddy, Y. C., Jain, S., Purushottam, M., et al. (2020) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000422 · Cited by 12
Kayser, R. R., Senter, M. S., Tobet, R., Raskin, M., Patel, S. R., & Simpson, H. B. (2021) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2021.100664 · Cited by 12
Self-citation
Metadata
- Authors
- Koran, L. M., Hanna, G. L., Hollander, E., Nestadt, G., & Simpson, H. B.
- Venue
- APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches
- Publisher
- American Psychiatric Association
- Published
- 2008-01-17
- Volume
- 164
- Issue
- 12 Suppl
- Pages
- 5-53
- OpenAlex
- W306343222
- Cited by
- 1,028
- References
- 302
- Citations by year
- 2026: 1 · 2025: 36 · 2024: 52 · 2023: 54 · 2022: 53 · 2021: 73 · 2020: 50 · 2019: 57 · 2018: 52 · 2017: 57 · 2016: 67 · 2015: 79 · 2014: 76 · 2013: 70 · 2012: 66
- FWCI
- 265.99
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- American Psychiatric Association Publishing eBooks (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- obsessive-compulsive disorder, treatment, psychotherapy, pharmacotherapy, cognitive behavioral therapy, selective serotonin reuptake inhibitors
- MeSH terms
- Adolescent, Adult, Age Factors, Child, Combined Modality Therapy, Female, Humans, Male, Obsessive-Compulsive Disorder, Patient Care Planning, Patient Compliance, Pregnancy, Psychiatric Status Rating Scales, Psychotherapy, Severity of Illness Index, Cognitive Behavioral Therapy, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review